Depletion of Gpbar1 in hepatocytes significantly protects against the progression from MASLD to metabolic dysfunction‐associated steatohepatitis (MASH) that is related to conjugated LCA. This evidence concerns the gene GPBAR1 and metabolic dysfunction-associated steatotic liver disease.